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Epidemiological research methods
Part VII. Epidemiological research in health planning
D. YACH, J. L: BOTHA
The goal of epidemiology is to improve the health status of
human populations. In our series thus far'-6 we have srressed
the need to use the correct design for epidemiological studies,
a sampling scheme that yields interpretable results, measure-
ments that are both valid and reliable, and finally the appro-
priate analysis. These methodological considerations are of
importance if the goal is to be reached. In this article we
assume that most of these issues have been adequately dealt
with and focus on how the results of epidemiological research
can be used by health planners to improve the health status of
regions and the country as a whole.
Under ideal circumstances health planning should take place
in a spiral fashion. A descriptive study is used to describe the
impact of disease in a particular community,2 .analyrical studies
are used to determine particular risk factors for the diseases
described,4,; interventions are applied by the local health
authority to reduce the impact of the risk factors and subse-
quent disease on a community.3 The effectiveness of the
intervention is evaluated at some point. If the intervention has
been successful the health status of a community will improve
over a certain period of time, this time period being a product
of both the rime it takes IQ implement the intervention as well
as the time it takes IQ conduct the evaluation. In reality, this
idealised epidemiological approach is not entirely possible and
there are impediments IQ using descriptive, analytical and
intervention studies. It is likely that health sratus improve-
ments will need greater effort at the beginning of the spiral
than as the optimal state is approached.
Descriptive studies in health planning
Recent articles have clearly demonsrrated the potential for
using surveys both as the means for motivating local health
workers about local health problems and as a means of pro-
viding important baseline information upon which the effec-
tiveness of later interventions can be measured. 7- 9 It is often,
however, difficult to select which outcomes are relevant and
should be measured.
This is particularly the case in small regional studies where
population sizes are relatively small, resulting in death rates
(infant mortality rates, for example) being unstable (having
very wide confidence intervals). One way of solving this
problem is to use several years of data to increase the number
of deaths in the numerator of the mortality rate. The short-
coming of this approach is that health planners at a regional
level are particularly interested in the rapid effects of their
changes in health services on outcomes such as mortality. A
more realistic approach is to use outcomes occurring more
commonly than death, such as disease rates, or compliance
rates in the case of tuberculosis, or the knowledge, anitudes
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and practices of a community with regard to oral rehydration
practices.
It is often difficult to decide which diseases to examine or
which subgroup (age, sex, race, for example) to focus on when
describing the impact of disease and death in a community.
This decision in itself often has a very important effect on the
later provision of resources. For example, one health planner
in a particular region may feel that common causes of childhood
mortality should be well documented in an initial study. This
investigator may have decided to ignore initially all the diseases
which affect people after the age of 5 years. He or she would
then not be focusing on injuries, tuberculosis (to a large
extent), hypertensive diseases and cancer. In a region nearby
with a similar profile of diseases, however, the policy maker
may have the prior belief that first-line anention should be
given to the diseases of people between the ages of 15 and 55
years. Clearly the results of the studies from the two areas
would come up with very different implications for the disrri-
bution of health resources.
Analytical studies in health planning
Causality
An epidemiologist in an academic research environment,
divorced from a parricular community, will tend IQ focus on
different risk factors for diseases from either the epidemiologist
practising in the field or the local health planner. To the
planner, risk factors which are amenable to change at either
the primary, secondary or tertiary level of prevention are of
prime consideration. IO- 12 Initially, however, it is important to
determine which risk factors are likely to be causally related to
the outcome being measured. The method of deciding whether
a particular risk factor is likely IQ be a causal agent has been
well described in the literature. l3 A causal decision is a
common-sense decision based on the balance of evidence from
all applicable studies, and is not scientific inference. Sacken er
al. l3 have published guidelines for this decision first suggested
by Bradford-Hill, a few of which will be described here.
Evidence for causality is srrongest if it comes from the study
with a randomised controlled design. ext in this design
hierarchy, a follow-up study is regarded as providing srronger
evidence than a case-eonrrol study, which in turn is srronger
than a descriptive study. Risk factors are quantified by using a
measure of the srrength of association such as the relative risk
or odds ratio (both of which have been described in previous
articles in this series";). In general, the higher the srrength of
association the more likely the risk factor is to be causally
related to the outcome (assuming that the role of confounders
has been carefully excluded):';
To test for causality, consistent results from a number of
studies conducted under a number of different settings using
different research methods should be obtained. A further test
of causality involves the temporal sequence of events. Subjects
should be exposed to the risk factor prior to the outcome
becoming manifest. This may sound a simple requirement but
often it is very difficult (especially in descriptive and case-
control studies) to ensure that this has in fact occurred. A
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recent example of unravelling the temporal sequence of. an
event has been the observed relationship between low choles-
terol levels and an increased risk of colon cancer. Initial
reports suggested that low cholesterol levels predisposed people
to higher colon cancer rates. Further investigation, however,
revealed that the low cholesterol level was, in fact, a response
to the early stage (undetected by diagnostic methods) of the
cancer. 14
It is also useful to find a dose-response relationship between
the risk factor and the outcome, although this should not be
regarded as an absolute requirement. Other guidelines sug-
gested by Sackett er a/. l3 include the need for findings to make
epidemiological and biological sense, but these are usually of
little assistance to researchers sinj:e they tend to reinforce
prevailing views and prevent the possibility of discovering new
and unexpected associations. Similarly, the requirement of a
specific association between the risk factor and a disease is
usually not realistic since most diseases (particularly chronic
diseases) are the result of the interaction between a number of
risk factors acting at different times.
We would suggest that a further guideline be added. This
involves looking at the difference between statistical and
clinical significance of results. A positive study (one that has
statistically significant differences between the exposed and
unexposed groups) should be examined carefully to determine
whether the statistically significant difference also happens to
be a clinically significant difference between the groupS.6
Statistically significant differences can be achieved in the
presence of trivial clinical differences as long as the sample
size is large enough. A clinically significant differeru:e occurs if
the difference is large enough to persuade readers to change
their clinical behaviour or to persuade community health
workers that policy changes are required. A study that shows
no relationship between a risk factor and an outcome should
be examined to determine whether this finding could be the
result of inadequate sample size (weak power).6 If this negative
study showed that there was a difference between the exposed
and unexposed groups that was clinically significant but did
not reach significance statistically, a so-called type II error
should be considered. Obviously this can be done only if a
negative study is published. Negative studies are often not
published because either' the publisher or the researcher thinks
publication is not warranted. This tends to bias the findings of
a literature review in favour of positive studies. In other
words, both studies with too small or too large a sample size
need to be carefully evaluated.
Once these guidelines for determining causality have been
applied to the literature it is necessary for policy makers firstly
to evaluate whether the published studies were conducted in
comparable populations and, secondly, to look at the overall
weight of the evidence before taking action. It will often be
necessary to take action in the presence of uncertainty so as to
err on the side of public' safety.1O Health planners at national
level often use uncertainty as a reason for delay in taking
public action. An example of this has been the reluctance of
governments to take strong action against the cigarette and
tobacco industry despite the overwhelming evidence that shows
the relationship between smoking and health. When faced
with the results of several studies and the weight of evidence
in favour of the risk factor being causal for disease, health
planners need to take account of the social, economic and
political consequences of their actions. ' 5-I8 In most cases the
epidemiological input unfortunately plays a much lower role
than that of pressure groups (e.g. industry, political parties,
religious groups).
Relative risk, attributable risk and absolute
rates
One way of asslstmg health plarmers to make a choice
between risk factors for intervening against a particular disease
is to consider the attributable risk and the effectiveness of the
intervention, as illustrated in Table 1. A study was conducted
to look at risk factors for disease X, which was felt to be an
important disease in a particular community. Three risk factors
(A, B and C) were found to play an independently important
role in the likelihood of death from the disease in question.
The association with A was higher than it was with B or C.
The health planners needed to know not only which risk
factors were important in terms of their relative importance,
but also which one would reswt in the largest decrease of
disease if an intervention was applied. From Table I it can be
seen that risk factor A had the highest relative risk. This
suggests that risk factor A is more likely to be a causal agent in
producing disease X. Risk factors B and C, both with relative
risks of 2, are important, but less so (it is assumed that all
three relative risks are statistically significant).
The relative risk, however, is not of much use to health
plarmers since it only suggests to them which agents are likely
to be causal. 19 A further examination of Table I shows that
only 2% of the people studied were actually exposed to risk
factor A, whereas 50% of the population were exposed to risk
factors Band C. When a measure of impact, the attributable
or aetiological risk, is calculated (using the formulae in Table
I) it can be seen that 7% of the deaths are potentially prevent-
able by removing the effect of risk factor A. Factors Band C
can be seen to be of far greater importance to the community,
even though the relative risks were lower than for risk factor
A.
The attributable risk, therefore, takes account of both the
relative risk and how common the risk factor is in the popula-
tion. When the relative risk (or odds ratio) is very high, it
strongly suggests that the association identified is real rather
Proportion of
total cases preventable
by the intervention~
0,07
0,25
0,17
Effectiveness
of the
intervention (%)t
95
75
50
0,07
0,33
0,33
Attributable
risk*(Pj
0,02
0,50
0,50
Relative risk (RR) at
tyears
follow-up
5
2
2
A
B
C
Risk factor
at initial
examination
TABLE I. ASSOCIATION OF RELATIVE RISK AND ATTRIBUTABLE RISK FOR DISEASE X AMONG POPULATION Y ON
INITIAL EXAMINATION
Proportion of
Ywith
risk factor
*Attributable risk = p(RR·l)
1 + P(RR-l)
t Effectiveness = efficacy x compliance (patient and health service).
~ Proportion of total cases preventable = attributable risk x eHectiveness.
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than something spurious derived from various confounding
factors. When the anributable risk is high the risk factor is of
importance to the health of the community.
While this is a hypothetical example, several examples in the
literature show that these kinds of results are applicable in
many settings, for example the relationship between high
systolic blood pressure, cardiomegaly on radiography, cigarette
smoking at baseline and subsequent risk over time of coronary
heart disease. .
Intervention studies in health planning
The health planner can be further assisted when information
on the effectiveness of the intervention is available. In Table I
the effectiveness of the intervention to reduce risk factor A has
been found to be 95%, factor B 75% and factor C 50%. This
can be applied to the anributable risk to work out the actual
expected reduction in deaths in the population if a particular
risk factor intervention programme succeeds. Information about
effectiveness should come from community-based studies and
not from randomised controlled trials conducted on highly
selected (unrepresentative of the community) hospitallclinic-
based studies. For example, many studies evaluating tuber-
culosis efficacy are conducted on patients who have been
selected as being compliant, unlikely to default, unlikely to
suffer severe side-effects, willing to be hospitalised for a
certain time period and able to be followed up with ease.
Community-based studies that evaluate the overall effective-
ness of a regimen (i.e. take into account patient and service
non-compliance, defaulting and side-effects) are more difficult
to conduct but yield results directly interpretable by a service.
We have already mentioned the need for interventions to be
aimed at amenable risk factors. It is also important that
interventions should be applied to the population rapidly.
Local or regionally based services are able to implement
interventions more rapidly than services at a nationalleve1.7,8,16
The time delay between completion of national studies and the
decision to act is usually due to factors outside the health
services.
African7 and international settings.20 It is not necessarily
dependent on improving the socio-economic status of the
community. The limitations are that the improvements may
occur only to a certain point and for specific diseases. Tuber-
culosis is unlikely to be improved without going on to yet
another approach which would involve socio-economic change.
By socio-economic change we mean improvement in housing,
water, sanitation, income, employment and education.
Interventions are often applied to high-risk groups or to
groups which are identified during a case-fmding programme.
Children below the third percentile (as illustrated in Fig. 1)
may be identified in a community-based survey of population
'a'. An intervention may be focused on improving their health
status. This approach provides benefit to selected individuals,
but is unlikely to have an epidemiological impact on the
disease in the community. From Fig. I it can be seen that the
median standardised weight for age of population 'a' is below
that of the reference population 'b'. Attention only to children
below the first percentile will result in a truncated distribution,
whereas a community-based approach may result in shifting
the entire distribution l9 from 'a' towards 'b' (for example
using the overall nutritional status of a group or entire com-
munity). The community-based or population-strategy
approach provides a small benefit to all the individuals.
Focusing on the high-risk group may result in rapid early
prevention of disease in those maximally at risk and is probably
best practised when resources are scarce and risks high.
However, meaningful long-term improvements in health will
result only if entire distributions are shifted. This usually
requires input from outside the health sector. Often a mix of
both approaches is required. In the case of nutrition pro-
grammes, high-risk children require regular food supplemen-
tation and need to be individually monitored. High-risk popu-
lations, however, require major social and economic inter-
ventions. The effectiveness of such programmes should be
evaluated in community-based surveys.
Fig. 1. High-risk v. community-based interventions.
Responsibility of the epidemiologist
The ultimate goal of epidemiologists is to improve the health
of the general population. Epidemiologists need to be aware
that this goal falls into the political-economic arena.
The theory and practice of epidemiology is profoundly
influenced by society, and epidemiologists therefore cannot be
b
(reference population)
Standardised weight tor age percentiles
a
(stUdy popUlation)
Percentage
of population
children below
the 3rd percentile
weight for age
Choice of interventions
Randomised control trials are regarded as the 'gold standard'
when evaluating the effectiveness of?Il intervention.4 Under
most service conditions, however, it is ethically not justified to
conduct such trials when using interventions of known effec-
tiveness. Under these conditions it may be more realistic to
conduct regular before-and-after studies, recognising that
contemporaneous changes and factors outside health care could
also account for the observed changes. Evaluation of the
impact of interventions using surveys, however, is expensive.
Community-based surveillance systems for sentinel events need
to be incorporated into he3.I.th service management with built-
in checks for under-reporting, over-reporting and misclassifi-
cation.
There are several different approaches to applying interven-
tions to populations. A disease-specific approadi can be
followed (such as that followed in the smallpox eradication
campaign). This approach has a role in reducing the impact of
diseases such as measles and tetanus but is unlikely to have a
major impact on diseases which are of multifactorial causation.
An alternative approach is to use some form of integrated
primary health care approach such as Unicefs GOBI-FFF (a
package including growth monitoring, oral rehydration, breast-
feeding, immunisation, food supplementation, family planning
and female education) approach for improving overall childhood
survival.20 This approach has had some success in the southern
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said to be neutra1.2 1 The choice of topics for research, the
variables that are chosen as potential risk factors or con-
founders, the choice of outcome measures and the actual
groups being studied are all choices made from a particular
ethical and/or political viewpoint. Neutrality in the practice of
epidemiology lies in ensuring methodological integrity. This
means collecting representative and interpretable samples,
obtaining valid and reliable measurements, conducting appro-
priate analyses and presenting all the data using relative risks
(or other measures of association), attributable risks and the
absolute rate in a population.22
Epidemiologists have a responsibility to both the community
within which they work and the health services of that com-
munity. Both groups (recipients and providers of care) need to
be consulted before research is conducted, to give consent to
the intended project and to be fully informed of the results
and implications of the research.
Epidemiology is never the sole basis for decision-making by
health planners. Epidemiolgists have tended to practise their
discipline without considering the needs of the health planner.
They have often been practising in academic and research
centres divorced from the reality of the needs of health
services at regional and national leve1.23 Studies need to be
conducted that carefully present the marginal cost-effectiveness
on the resulting health status of the population of alternative
policy approaches (both preventive and curative) at both the
national and the· regional level. There is an urgent need for
epidemiology to become incorporated in all aspects a11d levels
of health care so that epidemiology can be used as the basis for
health planning24,25 and the allocation of health-related
resources. To achieve this, epidemiologists need to take account
of the current pattern of control over resources26 (health and
non-health) that prevails in the RSA, and health planners need
at least a working knowledge of epidemiological research
methods.
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